Suchergebnisse - "Ufer, Mike"

PubPharm (132)

1

Endocrine profile of the kisspeptin receptor agonist MVT-602 in healthy premenopausal women with and without ovarian stimulation : results from 2 randomized, placebo-controlled clinical tricals

enthalten in: Fertility and sterility | 2024

von Abbara, A. | Ufer, M. | Voors-Pette, C. | +7

2

MODIFIED RELEASE FORMULATION

enthalten in: Europäisches Patentamt | 2023

von GALLI BRUNO | GLANTZMANN JEAN-MARIE | GRANDEURY ARNAUD | +6

3

Transition from Syringe to Autoinjector Based on Bridging Pharmacokinetics and Pharmacodynamics of the P2Y12 Receptor Antagonist Selatogrel in Healthy Subjects

enthalten in: Clinical pharmacokinetics | 2022

von Zenklusen, I. | Hsin, C. | Schilling, U. | +4

4

Assessment of the effect of the dual orexin receptor antagonist daridorexant on various indices of disease severity in patients with mild to moderate obstructive sleep apnea

enthalten in: Sleep medicine | 2022

von Boof, M. | Ufer, M. | Fietze, I. | +4

5

Abuse potential assessment of the new dual orexin receptor antagonist daridorexant in recreational sedative drug users as compared to suvorexant and zolpidem

enthalten in: Sleep | 2022

von Ufer, M. | Kelsh, D. | Schoedel, K. | +1

6

Transition from Syringe to Autoinjector Based on Bridging Pharmacokinetics and Pharmacodynamics of the $ P2Y_{12} $ Receptor Antagonist Selatogrel in Healthy Subjects

enthalten in: Clinical pharmacokinetics | 2021

von Zenklusen, I. | Hsin, C. | Schilling, U. | +4

7

Transition from Syringe to Autoinjector Based on Bridging Pharmacokinetics and Pharmacodynamics of the $ P2Y_{12} $ Receptor Antagonist Selatogrel in Healthy Subjects

enthalten in: Clinical pharmacokinetics | 2021

von Zenklusen, I. | Hsin, C. | Schilling, U. | +4

8

Transition from Syringe to Autoinjector Based on Bridging Pharmacokinetics and Pharmacodynamics of the $ P2Y_{12} $ Receptor Antagonist Selatogrel in Healthy Subjects

enthalten in: Clinical pharmacokinetics | 2021

von Zenklusen, I. | Hsin, C. | Schilling, U. | +4

9

Impact of Daridorexant, a Dual Orexin Receptor Antagonist, on Cardiac Repolarization Following Bedtime Dosing : Results from a Thorough QT Study Using Concentration-QT Analysis

enthalten in: Clinical drug investigation | 2021

von Schilling, U. | Henrich, A. | Muehlan, C. | +3

10

Effect of the novel dual orexin receptor antagonist daridorexant on night-time respiratory function and sleep in patients with moderate chronic obstructive pulmonary disease

enthalten in: Journal of sleep research | 2021

von Boof, M. | Dingemanse, J. | Brunke, M. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]